Akari Therapeutics Plc

Nasdaq:AKTX

Pharmaceutical Preparations·TAMPA, FL

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Akari Therapeutics Plc

Nasdaq:AKTX

Pharmaceutical Preparations·TAMPA, FL

CEO

Gaslightwala Abizer

CFO

Farag Kameel D.

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$16.8M

FY 2024

Net Income

-$10.0M

FY 2024

EPS (Diluted)

$0.00

FY 2024

Stock Price

$0.25

+1.2%

2026-03-06

52W Range

$0.22 – $1.73

P/E Ratio

—

Market Cap

$18.0B

Cash

$3.8M

FY 2024

Total Debt

$659,000

FY 2024

Net Cash

$3.2M

FY 2024

Enterprise Value

$18.0B

Debt / EBITDA

0.2x

FY 2024

EV / EBITDA

-1068.5x

Employees

—

Revenue

—

Adj. EBITDA

-$16.8M

FY 2024

Net Income

-$10.0M

FY 2024

EPS (Diluted)

$0.00

FY 2024

Stock Price

$0.25

+1.2%

2026-03-06

52W Range

$0.22 – $1.73

P/E Ratio

—

Market Cap

$18.0B

Cash

$3.8M

FY 2024

Total Debt

$659,000

FY 2024

Net Cash

$3.2M

FY 2024

Enterprise Value

$18.0B

Debt / EBITDA

0.2x

FY 2024

EV / EBITDA

-1068.5x

Employees

—

CEO

Gaslightwala Abizer

CFO

Farag Kameel D.